Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.
Year of Publication
Wright, J; Hillsamer, V L; Gore-Langton, R E; Cheson, B D
Oncology (Williston Park)
1589-90, 1593-4, 1597
Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Hematologic Neoplasms; Humans; Neoplasms; Protease Inhibitors; Pyrazines